Moderna Inc. stock falls Tuesday, underperforms market

This post was originally published on this site

© Terrence Horan


Shares of Moderna Inc. MRNA slipped 3.47% to $179.52 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.14% to 14,007.70 and the Dow Jones Industrial Average DJIA falling 0.03% to 31,375.83. The stock’s fall snapped a five-day winning streak. Moderna Inc. closed $9.74 short of its 52-week high ($189.26), which the company reached on February 8th.

The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.35% to $105.40, Amgen Inc. AMGN fell 0.39% to $236.65, and AstraZeneca PLC ADR AZN rose 0.70% to $50.41. Trading volume (8.4 M) remained 17.6 million below its 50-day average volume of 26.0 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading